ResMed Inc. RMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.59B | 1.52B | 1.52B | 1.49B | 1.44B |
| Total Depreciation and Amortization | 219.20M | 218.64M | 237.75M | 220.80M | 214.36M |
| Total Amortization of Deferred Charges | 19.11M | 25.51M | 25.57M | 25.40M | 25.41M |
| Total Other Non-Cash Items | 53.10M | 112.63M | 114.20M | 108.43M | 104.30M |
| Change in Net Operating Assets | -113.65M | -74.24M | -7.12M | 74.00M | 101.39M |
| Cash from Operations | 1.77B | 1.81B | 1.89B | 1.91B | 1.88B |
| Capital Expenditure | -162.06M | -156.29M | -135.74M | -122.89M | -114.99M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -357.69M | -350.72M | -163.98M | -139.10M | -139.77M |
| Divestitures | 450.82M | -- | -- | -- | -- |
| Other Investing Activities | -31.64M | -38.19M | 4.47M | -7.03M | -9.00K |
| Cash from Investing | -100.57M | -545.20M | -295.26M | -269.02M | -254.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -260.00M | -10.00M | -10.00M | -10.00M | -10.00M |
| Issuance of Common Stock | 69.95M | 74.50M | 75.35M | 76.94M | 74.26M |
| Repurchase of Common Stock | -1.51B | -721.87M | -622.08M | -522.04M | -418.44M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -356.87M | -349.66M | -340.16M | -330.63M | -320.74M |
| Other Financing Activities | -- | -- | -10.86M | -10.86M | -10.86M |
| Cash from Financing | -2.05B | -1.01B | -907.75M | -796.58M | -685.77M |
| Foreign Exchange rate Adjustments | 11.29M | 6.18M | 40.85M | 46.23M | 14.66M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -373.11M | 259.78M | 727.80M | 895.13M | 957.49M |